Janus Henderson Group PLC Curis Inc Transaction History

Janus Henderson Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $9,931 - $33,990	-13,988 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $416,654 - $925,298	-180,370 Reduced 92.8%	13,988 $33,000
Q4 2021 Feb 14, 2022	SELL	$4.45 - $8.09 $1.83 Million - $3.32 Million	-410,227 Reduced 67.85%	194,358 $926,000
Q3 2021 Nov 16, 2021	BUY	$6.94 - $8.85 $333,640 - $425,463	48,075 Added 8.64%	604,585 $4.74 Million
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $4.15 Million - $9.05 Million	556,510 New	556,510 $4.49 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.